By 2030, the market is forecasted to reach $32.87 billion, propelled by the approval of new GLP-1 drugs, expansion of obesity clinics, and enhanced insurance coverage
Heart Health: Folic Acid helps regulate homocysteine levels in the blood, a key factor in maintaining cardiovascular wellness
The essential role of glucagon in the pathogenesis of diabetes mellitus
Tirzepatide is the generic form of the brand name known as MonjauroTM or ZepboundTM
Others have struck partnerships leveraging complementary strengths: Zydus with Lupin and Torrent, Natco with Eris, Biocon with Ajanta
Cold-chain integrity, consistent supply availability, and digital support for adherence and refill management have become critical differentiators as therapies scale into direct-to-patient delivery models